Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MedImmune to boost FluMist production

MEDI will expand production of its FluMist influenza vaccine by one million doses to help alleviate flu vaccine shortages,

Read the full 190 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE